The harsh reality of our struggle is that most ppl see PFS patients as an inconvenient nuisance esp since young balding men are not a sympathetic social category.
People have cared about cigarettes and nicotine for decades and everybody knows that the tobacco industry has held a death grip on Americans for generations.
I think what is needed is some other reason to get people interested in PFS. The FDA refused to even disclose that finasteride disrupts neurosteroid production on the product label and they gave a totally lazy and BS reason. But when people start to get interested in the underlying science, people will be more likely to look at PFS patients as an interesting and tragic case study.
Neurosteroid science is beyond the scope of mainstream science now, epigenetics is practically further out in my opinion, but once the causal scientific mechanisms start to become clearer and more practical, people will possibly be willing to revisit this.
Sage Therapeutics had a trial for brexanalone for major depression but it failed largely because they tried to cut corners and design a bad clinical trial. I think they are trying it again with a better designed study.
EDIT: It looks like Sage (with Biogen) recently re-did their phase 3 trials for the pill version of Zuranolone for major depression and the results were acceptable. They’ll apply for an NDA by the end of 2022 and hopefully this drug will be available to try for PFS patients to see if it an provide any symptomatic relief.